Puerto Rico Drug Production Lagging Badly, Gottlieb Tells Congress

International Pharmaceutical Regulatory Monitor
A A
The FDA continues to work to restore drug manufacturing crippled by hurricane Maria in Puerto Rico, with special response teams set up to tackle the job, but none of the plants has reached 70 percent of its pre-storm capacity, FDA Commissioner Scott Gottlieb told a congressional committee.

To View This Article:

Login

Subscribe To International Pharmaceutical Regulatory Monitor